ERBB2 and breast cancer: Similarly, among the subtypes, FKBP12 loss correlated with lower pCR in TNBC patients (n = 67, P = 0.003), but not in patients with luminal (n = 65, P >0.05) or HER2+ breast cancer (n = 34, P >0.05).